Skip to content
Home
Leadership
Locations
Careers
Investors
Media
Press Releases
SEC Filings
Governance
Board Committee
Board of Directors
Governance Documents
Investor Relations Contacts
Investor Materials
Analyst Coverage
Benchmark – Bill Sutherland
Maxim Group – Anthony Vendetti
Freedom Capital Markets – Gene Mannheimer
Contact
Nutex Health
Home
Leadership
Locations
Careers
Investors
Media
Press Releases
SEC Filings
Governance
Board Committee
Board of Directors
Governance Documents
Investor Relations Contacts
Investor Materials
Analyst Coverage
Benchmark – Bill Sutherland
Maxim Group – Anthony Vendetti
Freedom Capital Markets – Gene Mannheimer
Contact
Posts in March 2024
by
919496pwpadmin
March 28, 2024
NUTEX HEALTH REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS
TOTAL REVENUE OF $247.6 MILLION FOR THE YEAR ENDED 2023 VS $219.3 MILLION IN 2022, AN […]
0
read more
by
919496pwpadmin
March 15, 2024
NUTEX HEALTH ANNOUNCES PRELIMINARY 2023 HEADLINE FINANCIALS AND PROVIDES UPDATE ON THE TIMING OF ITS 10-K FILING
HOUSTON, March 15, 2024 /PRNewswire/ — Nutex Health Inc. (“Nutex Health” or the “Company”) (NASDAQ: NUTX), […]
0
read more